News Releases

October 2, 2019   NextCure Announces Promotion of Timothy Mayer, Ph.D., to Chief Operating Officer

October 1, 2019   NextCure to Present Clinical Data from NC318 Phase 1/2 Clinical Trial at 34th Annual Meeting of SITC

September 3, 2019   NextCure to Present at Morgan Stanley 17th Annual Global Healthcare Conference

August 12, 2019   NextCure Reports Second Quarter 2019 Financial Results

June 10, 2019   NextCure Reports First Quarter 2019 Financial Results

May 13, 2019   NextCure Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 8, 2019   NextCure Announces Pricing of Initial Public Offering of Common Stock

March 4, 2019   NextCure and Yale Publish Nature Medicine Paper Detailing Novel Immunomedicine Target Siglec-15

February 12, 2019   NextCure Announces Formation of Scientific Advisory Board to Guide Development of its Portfolio of Immunomedicines